Medical Cannabis News

Synonyms: 
mmj
Fri
20
Aug

Study to Determine if Psychedelics Help to Quit Cigarette Smoking

man smoking

Psychedelics could provide just the right push to overcome addiction patterns like smoking.

Tobacco use is the leading preventable cause of death in the United States, according to the U.S. Centers for Disease Control and Prevention and the U.S. Department of Health and Human Services. But researchers think psychedelics have a unique ability to unlock patterns in the brain that lead to addiction—notably nicotine addiction.

Mydecine Innovations Group announced on August 18 it has signed a five-year research agreement with Johns Hopkins University (JHU) School of Medicine, to study the efficacy of psychedelic formulations for smoking cessation.

Thu
19
Aug

Cantourage brings the first medical cannabis flowers from Jamaica to the European market via its Fast Track Access Platform

marijuana plant

As of today, Jamaican Lumir cannabis flowers are available in German pharmacies for the first time - providing a new, indica-dominant product to patients in Germany

Cantourage is partnering with Cannim, Jamaica's leading cultivator, and will use its Fast Track Access Platform to provide Cannim's products to patients in the German medical market

Wed
18
Aug

Can Marijuana Worsen A Mental Illness?

female looking out a window

Studies show a connection between mental illness and marijuana use, but it’s one that’s complex.

The use of marijuana has many scientifically proven health benefits. These can be as simple as helping users relax or as complex as managing chronic pain or stimulating appetite. There’s a lot we don’t know about marijuana, especially when discussing its negative side effects; aside from red eyes and the occasional bout of paranoia, can the use of the plant worsen conditions like mental illness?

There’s not a lot of evidence or scientific research out there, but some studies have found links between marijuana use and some mental health conditions, such as depression and even psychosis.

Mon
16
Aug

Psychedelic Toad Venom Clinical Research Boosted by $80M in Funding

image of toad

The money will boost Beckley Psytech’s research on 5-MeO-DMT and psilocybin for the treatment of depression. (Image: Shutterstock)

Oxford-based startup Beckley Psytech in the United Kingdom announced August 15 that it raised $80 million to ramp up clinical trials and research using a pharmaceutical formulation of ​​5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine), a powerful compound produced endogenously by Sonoran Desert toad venom, to treat depression. 

The Series B financing was initially set at $50 million—but was upgraded to $80 million due to “overwhelming interest” from investors to support accelerating the clinical development of its psychedelic medicine research pipeline.

Mon
16
Aug

Changes in Canada's cannabis retail market two years after legalization

marijuana plant

A recent study by public health researchers published in Drug and Alcohol Review documents the rapid expansion of the cannabis retail market in Canada in the two years following legalization.

Similar to the team's previous study 6 months after legalization, they found there were twice as many cannabis stores concentrated in low-income neighborhoods compared to high-income neighborhoods.

Mon
16
Aug

Family and friends mourn death of teen who inspired families to explore cannabis for seizures

CALGARY -- The death of 15-year-old Mia Wilkinson has rocked her family and friends, the teen girl passed away suddenly on August 12.

“It really hits home and it's gut wrenching,” said Kendra Myhre, a long-time friend of the family.

“I am so upset and hurt and devastated.”

Mia was diagnosed with Ohtahara syndrome when she was a baby, which causes her to have severe seizures and sometimes she could have up to 100 episodes every day. When Mia was about seven years old, her mom Sarah explored cannabis oil and it changed Mia’s life.

Since then, Sarah has worked to educate and counsel other families about the benefits of cannabis for children who suffer from severe seizures.

Tue
10
Aug

Hemp, Inc. Pleased to See Growing Numbers of Elite Athletes Incorporating CBD in Training, Recovery

Hemp, Inc. (OTC PINK: HEMP), an established leader in the industrial hemp market, is pleased to see top-level athletes embracing CBD as part of their training programs.

Mon
09
Aug

Do CBD Regulations Need Federal Cannabis Reform? Some Say No

It feels as 2019 was a long while ago however some things can’t be forgotten. Back in July of 2019 a staff director for Republicans on the House Judiciary Committee was placed behind other members on the dais. This staff director Brendan was paying attention to all-too-rare bipartisan harmony. Both sides formed a collective understanding: it is time for the federal marijuana prohibition to end.

Mon
09
Aug

Cannabis Isn’t Food. Don’t Test It Like It Is.

We continue to see several conflations and misconceptions voiced in the discussion about microbial safety standards for cannabis products. The foundation for these misconceptions is the idea that cannabis testing regulations should mimic the food industry. We reject this idea because cannabis flower has two major departures from food: it contains high concentrations of antibiotics and it is dried and inhaled.

Cannabis Flower Contains High Concentrations of Antibiotics

As much as 20% of cannabis flower weight/volume is made up of cannabinoids, which are potent antibiotics. We have not seen any food on the market that is 20% (weight/volume) antibiotic.

Mon
09
Aug

Study suggests cannabis can induce a psychedelic-like “oceanic” experience

Psychedelic drugs such as psilocybin and LSD can induce an experience known as oceanic boundlessness, which is characterized by a feeling of oneness with the world and a sense of awe. New research, published in the Journal of Psychopharmacology, provides some preliminary evidence that high doses of cannabis can also produce this type of altered state of consciousness.

Pages

Subscribe to RSS - Medical Cannabis News